6.97
-0.24 (-3.26%)
| Penutupan Terdahulu | 7.21 |
| Buka | 7.37 |
| Jumlah Dagangan | 40,281 |
| Purata Dagangan (3B) | 320,826 |
| Modal Pasaran | 5,810,324 |
| Harga / Buku (P/B) | 0.560 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -792.40 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 9.23% |
| Nisbah Semasa (MRQ) | 5.20 |
| Aliran Tunai Operasi (OCF TTM) | -12.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.16 M |
| Pulangan Atas Aset (ROA TTM) | -94.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -342.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | TransCode Therapeutics, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | -0.50 |
|
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company’s lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.15% |
| % Dimiliki oleh Institusi | 9.46% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Warberg Asset Management Llc | 31 Mar 2025 | 1,786 |
| Corsair Capital Management, L.P. | 31 Mar 2025 | 1,428 |
| Southstate Corp | 31 Mar 2025 | 643 |
| Julat 52 Minggu | ||
| Median | 10.00 (43.47%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 16 Apr 2025 | 10.00 (43.47%) | Beli | 10.00 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |